129 related articles for article (PubMed ID: 9156416)
1. Treatment of deep vein thrombosis with low-molecular-weight heparins: a consensus statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH).
Harenberg J; Schmitz-Huebner U; Breddin KH; Hass S; Heinrich F; Heinrichs C; Kienast J; Roebruck P; Theiss W; Wenzel E
Semin Thromb Hemost; 1997; 23(1):91-6. PubMed ID: 9156416
[TBL] [Abstract][Full Text] [Related]
2. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
Fiessinger JN
Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
[TBL] [Abstract][Full Text] [Related]
5. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
[TBL] [Abstract][Full Text] [Related]
6. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin in the treatment of pulmonary embolism.
Ageno W; Turpie AG
Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
[TBL] [Abstract][Full Text] [Related]
8. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
9. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
Blatný J; Fiamoli V
Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
Cziraky MJ; Spinler SA
Clin Pharm; 1993 Dec; 12(12):892-9. PubMed ID: 8137606
[TBL] [Abstract][Full Text] [Related]
11. Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins.
Pini M
Semin Thromb Hemost; 1997; 23(1):51-4. PubMed ID: 9156411
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of venous thromboembolism with low-molecular-weight heparins].
Haas S; Haas P; Creutzig A
Vasa; 2000 Feb; 29(1):5-10. PubMed ID: 10731882
[TBL] [Abstract][Full Text] [Related]
13. Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis.
Büller HR
Haemostasis; 1998; 28 Suppl 3():91-4. PubMed ID: 10069767
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of thromboses with low-molecular-weight heparins].
Haas S; Haas P
Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of deep venous thrombosis].
Bounameaux H
Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
[TBL] [Abstract][Full Text] [Related]
16. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
Berkowitz SD
Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of thromboses with low molecular weight heparins].
Haas S
Z Kardiol; 1993; 82 Suppl 2():77-80. PubMed ID: 8392238
[TBL] [Abstract][Full Text] [Related]
19. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).
Bratt G; Aberg W; Johansson M; Törnebohm E; Granqvist S; Lockner D
Thromb Haemost; 1990 Dec; 64(4):506-10. PubMed ID: 1964751
[TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.
Matsagas MI
Int Angiol; 2004 Dec; 23(4):305-16. PubMed ID: 15767978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]